"entered into a binding share subscription offer with Mangwana Capital"
"has coordinated up to a $10 million placement to institutional Zimbabwe investors"
"issuance of 151,515,152 shares at a share price of A$0.10"
"Participants also receive an option to subscribe for one share for every four shares subscribed"
"exercisable at A$0.30 with a two-year option period"
"funds raised will be used to advance the Cabora Bassa project"
"Mukuyu-2 flow testing and advancement of early monetisation opportunities"
"purchase of long lead items for shallow exploration wells targeting the Eastern Margin and Basin Margin plays"
"engaged in active discussions on multiple fronts to bring in strategic participants to the Cabora Bassa project"
"through completion of a farmout to accelerate development of the project"
https://oilman.beehiiv.com/p/oilman-jims-letter-july-31-2024
Worth reading
- Forums
- ASX - By Stock
- IVZ
- IVZ Share Price
IVZ Share Price, page-22235
-
- There are more pages in this discussion • 729 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
Add IVZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $107.6M |
Open | High | Low | Value | Volume |
7.4¢ | 7.4¢ | 7.1¢ | $50.01K | 700.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 96052 | 7.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.2¢ | 96836 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 96052 | 0.071 |
7 | 221045 | 0.070 |
3 | 121823 | 0.069 |
4 | 349117 | 0.068 |
4 | 214984 | 0.067 |
Price($) | Vol. | No. |
---|---|---|
0.072 | 96836 | 5 |
0.073 | 262490 | 2 |
0.074 | 478693 | 3 |
0.075 | 643787 | 2 |
0.076 | 883262 | 4 |
Last trade - 14.34pm 10/10/2024 (20 minute delay) ? |
Featured News
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
IVZ (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online